Progress and Impact of 13 Years of the Global Programme to Eliminate Lymphatic Filariasis on Reducing the Burden of Filarial Disease

Por Ramaiah, K. D., Ottesen, Eric A.
Publicado no PLoS Negl Trop Dis (2014)

The Global Programme to Eliminate Lymphatic Filariasis: Health Impact after 8 Years

Por Ottesen, Eric A., Hooper, Pamela J., Bradley, Mark, Biswas, Gautam
Publicado em 2008

Antibody to the Filarial Antigen Wb123 Reflects Reduced Transmission and Decreased Exposure in Children Born following Single Mass Drug Administration (MDA)

Por Steel, Cathy, Kubofcik, Joseph, Ottesen, Eric A., Nutman, Thomas B.
Publicado em 2012

Assessing Progress in Reducing the At-Risk Population after 13 Years of the Global Programme to Eliminate Lymphatic Filariasis

Por Hooper, Pamela J., Chu, Brian K., Mikhailov, Alexei, Ottesen, Eric A., Bradley, Mark
Publicado no PLoS Negl Trop Dis (2014)

RRR for NNN—a rapid research response for the Neglected Tropical Disease NGDO Network: a novel framework to challenges faced by the global programs targeting neglected tropical dis...

Por Toledo, Chelsea E., Jacobson, Julie, Wainwright, Emily C., Ottesen, Eric A., Lammie, Patrick J.
Publicado no Int Health (2016)

The Economic Benefits Resulting from the First 8 Years of the Global Programme to Eliminate Lymphatic Filariasis (2000–2007)

Por Chu, Brian K., Hooper, Pamela J., Bradley, Mark H., McFarland, Deborah A., Ottesen, Eric A.
Publicado em 2010

Global Programme to Eliminate Lymphatic Filariasis: The Processes Underlying Programme Success

Por Ichimori, Kazuyo, King, Jonathan D., Engels, Dirk, Yajima, Aya, Mikhailov, Alexei, Lammie, Patrick, Ottesen, Eric A.
Publicado no PLoS Negl Trop Dis (2014)

Predictive vs. Empiric Assessment of Schistosomiasis: Implications for Treatment Projections in Ghana

Por Kabore, Achille, Biritwum, Nana-Kwadwo, Downs, Philip W., Soares Magalhaes, Ricardo J., Zhang, Yaobi, Ottesen, Eric A.
Publicado em 2013

Integrated Implementation of Programs Targeting Neglected Tropical Diseases through Preventive Chemotherapy: Proving the Feasibility at National Scale

Por Linehan, Mary, Hanson, Christy, Weaver, Angela, Baker, Margaret, Kabore, Achille, Zoerhoff, Kathryn L., Sankara, Dieudonne, Torres, Scott, Ottesen, Eric A.
Publicado em 2011

Integrated Implementation of Programs Targeting Neglected Tropical Diseases through Preventive Chemotherapy: Identifying Best Practices to Roll Out Programs at National Scale

Por Hanson, Christy, Weaver, Angela, Zoerhoff, Kathryn L., Kabore, Achille, Linehan, Mary, Doherty, Amy, Engels, Dirk, Savioli, Lorenzo, Ottesen, Eric A.
Publicado em 2012

Localized Eosinophil Degranulation Mediates Disease in Tropical Pulmonary Eosinophilia

Por O'Bryan, Laura, Pinkston, Paula, Kumaraswami, V., Vijayan, V., Yenokida, Gordon, Rosenberg, Helene F., Crystal, Ronald, Ottesen, Eric A., Nutman, Thomas B.
Publicado em 2003

The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000–2014)

Por Turner, Hugo C., Bettis, Alison A., Chu, Brian K., McFarland, Deborah A., Hooper, Pamela J., Ottesen, Eric A., Bradley, Mark H.
Publicado no Infect Dis Poverty (2016)

Determinants of Success in National Programs to Eliminate Lymphatic Filariasis: A Perspective Identifying Essential Elements and Research Needs

Por Kyelem, Dominique, Biswas, Gautam, Bockarie, Moses J., Bradley, Mark H., El-Setouhy, Maged, Fischer, Peter U., Henderson, Ralph H., Kazura, James W., Lammie, Patrick J., Njenga, Sammy M., Ottesen, Eric A., Ramaiah, Kapa D., Richards, Frank O., Weil, Gary J., Williams, Steven A.
Publicado em 2008

National Mass Drug Administration Costs for Lymphatic Filariasis Elimination

Por Goldman, Ann S., Guisinger, Victoria H., Aikins, Moses, Amarillo, Maria Lourdes E., Belizario, Vicente Y., Garshong, Bertha, Gyapong, John, Kabali, Conrad, Kamal, Hussein A., Kanjilal, Sanjat, Kyelem, Dominique, Lizardo, Jefrey, Malecela, Mwele, Mubyazi, Godfrey, Nitièma, P. Abdoulaye, Ramzy, Reda M. R., Streit, Thomas G., Wallace, Aaron, Brady, Molly A., Rheingans, Richard, Ottesen, Eric A., Haddix, Anne C.
Publicado em 2007

A Multicenter Evaluation of Diagnostic Tools to Define Endpoints for Programs to Eliminate Bancroftian Filariasis

Por Gass, Katherine, Beau de Rochars, Madsen V. E., Boakye, Daniel, Bradley, Mark, Fischer, Peter U., Gyapong, John, Itoh, Makoto, Ituaso-Conway, Nese, Joseph, Hayley, Kyelem, Dominique, Laney, Sandra J., Legrand, Anne-Marie, Liyanage, Tilaka S., Melrose, Wayne, Mohammed, Khalfan, Pilotte, Nils, Ottesen, Eric A., Plichart, Catherine, Ramaiah, Kapa, Rao, Ramakrishna U., Talbot, Jeffrey, Weil, Gary J., Williams, Steven A., Won, Kimberly Y., Lammie, Patrick
Publicado em 2012

Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation

Por Chu, Brian K., Deming, Michael, Biritwum, Nana-Kwadwo, Bougma, Windtaré R., Dorkenoo, Améyo M., El-Setouhy, Maged, Fischer, Peter U., Gass, Katherine, Gonzalez de Peña, Manuel, Mercado-Hernandez, Leda, Kyelem, Dominique, Lammie, Patrick J., Flueckiger, Rebecca M., Mwingira, Upendo J., Noordin, Rahmah, Offei Owusu, Irene, Ottesen, Eric A., Pavluck, Alexandre, Pilotte, Nils, Rao, Ramakrishna U., Samarasekera, Dilhani, Schmaedick, Mark A., Settinayake, Sunil, Simonsen, Paul E., Supali, Taniawati, Taleo, Fasihah, Torres, Melissa, Weil, Gary J., Won, Kimberly Y.
Publicado em 2013